Chargement en cours...
Pharmacological treatment for familial amyloid polyneuropathy
BACKGROUND: Disease‐modifying pharmacological agents for transthyretin (TTR)‐related familial amyloid polyneuropathy (FAP) have become available in the last decade, but evidence on their efficacy and safety is limited. This review focuses on disease‐modifying pharmacological treatment for TTR‐relate...
Enregistré dans:
| Publié dans: | Cochrane Database Syst Rev |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley & Sons, Ltd
2020
|
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7170468/ https://ncbi.nlm.nih.gov/pubmed/32311072 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012395.pub2 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|